The Commission has mobilised another €122 million from its research and innovation programme, Horizon 2020, for urgently needed research into the coronavirus. The new call for expressions of interest contributes to the Commission's €1.4 billion pledge to the Coronavirus Global Response initiative, launched by President Ursula von der Leyen on 4 May 2020.
The new call is the newest addition to a range of EU-funded research and innovation actions to fight the coronavirus which complements earlier actions to develop diagnostics, treatments and vaccines by strengthening capacity to manufacture and deploying available solutions in order to address the needs. It will also improve understanding of the behavioural and socio-economic impacts of the epidemic.
The projects funded under this call should repurpose manufacturing for rapid production of medical supplies and equipment needed for testing, treatment and prevention, as well as develop medical technologies and digital tools to improve detection, surveillance and patients care. Europe, and the world, urgently need innovative solutions to mitigate the outbreak, and to better care for patients, survivors, vulnerable groups, frontline health care staff and their communities. New research will learn from large groups of patients (cohorts) across Europe and better understanding of the behavioural and socio-economic impacts of the coronavirus epidemic could help improve treatment and prevention strategies.
The new solutions need to be available and affordable for all, in line with the principles of the Coronavirus Global Response. For this purpose, the Commission will include rapid data-sharing clauses in grant agreements, resulting from this new call, to ensure that findings and outcomes can be put to use immediately.
The new call will cover five areas with the following indicative budgets:
This new special call under Horizon 2020 complements earlier actions to support 18 projects with €48.2 million to develop diagnostics, treatments, vaccines and preparedness for epidemics, as well as the €117 million invested in 8 projects on diagnostics and treatments through the Innovative Medicines Initiative, and measures to support innovative ideas through the European Innovation Council. It implements Action 3 of the ERAvsCorona Action Plan, a working document resulting from dialogues between the Commission services and national institutions.
News
Opinion
BATTERIES
Juan Cristóbal García
Senior R&D&I Consultant
Publication
LIFE
We present you the WHITE PAPER of the LIFE Programme, particularly valuable if you are thinking of submitting your proposal to the 2020 call.
To maximise the success and impact of a project, we manage the communication and dissemination activities, but we also define a social innovation strategy and tools to measure its impact.
We are experts in European funding programmes, which provide the opportunity to finance the development and market access of your company's innovative projects.
We can help you with cascading funding, an EC mechanism to distribute public funding to help SMEs developing digital innovation.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.